Analysis and Commentary STEVEN GROSSMAN 1/21/21 Analysis and Commentary STEVEN GROSSMAN 1/21/21 Leadership and FDA Appropriation for FY 22 Read More Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
Analysis and Commentary STEVEN GROSSMAN 1/21/21 Analysis and Commentary STEVEN GROSSMAN 1/21/21 Leadership and FDA Appropriation for FY 22 Read More
Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Advocacy at a Glance STEVEN GROSSMAN 1/22/21 Dr. Woodcock is the new Acting Commissioner. Alliance members and other FDA stakeholders are encouraged to express thanks to Congress for supporting FDA. Read More
